These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9069704)

  • 1. Cholesterol reduction and coronary prevention.
    Prabhakaran D
    Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of pravastatin on coronary events after myocardial infarction.
    Hazzard WR; Ettinger WH
    N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid-lowering therapy for average lipid levels: the CARE trial.
    Sprecher DL
    Cleve Clin J Med; 1997 Mar; 64(3):129-31. PubMed ID: 9068221
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary prevention of coronary artery disease.
    Domanski MJ
    N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
    [No Abstract]   [Full Text] [Related]  

  • 7. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 9. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
    Maron DJ
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):18-9. PubMed ID: 16265253
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of pravastatin on coronary events after myocardial infarction.
    Auerbach I; Behar S; Motro M
    N Engl J Med; 1997 Mar; 336(13):962. PubMed ID: 9072702
    [No Abstract]   [Full Text] [Related]  

  • 11. [CARE[ Cholesterol and Recurrent Events Trial]].
    Oida K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():427-32. PubMed ID: 11347108
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
    Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E
    N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of coronary events by pravastatin--is lowering low-density lipoprotein cholesterol the answer?
    Halle M; Bery A; Keul J
    Am J Cardiol; 1997 Sep; 80(5):683. PubMed ID: 9295011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 16. Lowering cholesterol with drugs and diet.
    Pedersen TR
    N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin and coronary heart disease.
    Assmann G; Schulte H; Cullen P
    Circulation; 1998 Dec 22-29; 98(25):2933-4. PubMed ID: 9860800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.